or search on
|Title:||Gaps in optimal care for lung cancer|
|Authors:||Vinod SK; Armstrong B; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L|
|Categories:||Treatment - Combinations of Localised and Systemic Therapies|
Cancer Type - Lung Cancer
|Keywords:||Australia; New South Wales; pathology; Questionnaires; radiotherapy; Registries; Research; surgery; survival; therapy; utilization; cancer; Wales; cancer registry; diagnosis; Female; Gender; Guidelines; Lung; methods|
|Journal Title:||Journal of Thoracic Oncology|
|Page number start:||871|
|Page number end:||879|
|Abstract:||PURPOSE: Lung cancer is the leading cause of cancer death in Australia, but little is known about how Australian patients with this disease are managed. METHODS: Lung cancer patients diagnosed from November 1, 2001 to December 31, 2002 were identified through the population-based New South Wales Central Cancer Registry. Information was collected on diagnosis, staging, referrals, and treatment. Cross-tabulations and logistic regression examined factors related to not receiving cancer-specific therapy. RESULTS: There were 2931 potentially eligible patients registered by the Central Cancer Registry and completed questionnaires were obtained for 1812 patients (62%); median age 71 years and 66% men. The pathology was non-small cell in 71%, small cell in 15% and not confirmed in 13% of patients. Eleven percent of patients did not see a lung cancer specialist and 33% received no cancer-specific therapy after initial diagnosis. Treatment utilization rates were 17% for surgery, 39% for radiotherapy, and 30% for chemotherapy. Factors significantly associated with having no cancer-specific therapy included female gender, older age, weight loss, poorer performance status, advanced or unknown disease stage, and consultation with a low patient volume lung cancer specialist or a non-lung cancer specialist. The median survival was 172 days and 2-year crude survival was 17%. CONCLUSIONS: Treatment patterns were in broad concordance with present national guidelines. Nevertheless, a significant proportion of lung cancer patients did not receive cancer-specific therapy. Treatment decisions should be multidisciplinary and decision-makers should include experienced lung cancer specialists|
|Programme:||Health Services Research; Lung Cancer|
|Division:||Cancer Research Division|
|Appears in Collections:||Research Articles|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.